Heron Therapeutics (HRTX) Inventory (2016 - 2026)

Heron Therapeutics has reported Inventory for 11 years, with the latest figure at $92.5 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 62.54% year-over-year to $92.5 million; the trailing twelve-month figure through Mar 2026 stood at $92.5 million (up 62.54% YoY), and the FY2025 full-year result was $92.7 million, up 74.47% from the prior year.
• Inventory for Q1 2026 stood at $92.5 million, roughly flat from $92.7 million in the prior quarter.
• The five-year high for Inventory was $92.7 million in Q4 2025, with the low at $100000.0 in Q1 2024.
• Historically, Inventory has averaged $54.9 million across 5 years, with a median of $53.2 million in 2024.
• Annual changes were most pronounced in 2024 — Inventory plunged 99.81% — and 2025, when it surged 56832.0%.
• Heron Therapeutics' Inventory stood at $54.6 million in 2022, then slipped by 22.84% to $42.1 million in 2023, then rose by 26.24% to $53.2 million in 2024, then surged by 74.47% to $92.7 million in 2025, then fell by 0.22% to $92.5 million in 2026.
• The last three Inventory figures came in at $92.5 million (Q1 2026), $92.7 million (Q4 2025), and $70.0 million (Q3 2025), per Business Quant data.